Clinical Trials · NCT01937598
Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Michael A. Nauck
- Enrollment
- 16
- Start date
- Aug 2013
- Locations
- 1 site, Germany
- Primary endpoint
- Incremental Area Under the Plasma Glucose (BG) Concentration-time Profile (AUC)